Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 282

1.

B cell depletion therapy in systemic lupus erythematosus.

Anolik J, Sanz I, Looney RJ.

Curr Rheumatol Rep. 2003 Oct;5(5):350-6. Review.

PMID:
12967516
2.

B-cell-targeted therapy for systemic lupus erythematosus.

Sabahi R, Anolik JH.

Drugs. 2006;66(15):1933-48.

PMID:
17100405
3.
4.

B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.

Eisenberg R, Albert D.

Nat Clin Pract Rheumatol. 2006 Jan;2(1):20-7. Review.

PMID:
16932648
5.

B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.

Kumar S, Benseler SM, Kirby-Allen M, Silverman ED.

Pediatrics. 2009 Jan;123(1):e159-63. doi: 10.1542/peds.2008-2361. Epub 2008 Dec 15.

PMID:
19074962
6.

T- and B-cell abnormalities in systemic lupus erythematosus.

Nagy G, Koncz A, Perl A.

Crit Rev Immunol. 2005;25(2):123-40. Review.

PMID:
15952933
7.

Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus.

Anolik JH, Barnard J, Cappione A, Pugh-Bernard AE, Felgar RE, Looney RJ, Sanz I.

Arthritis Rheum. 2004 Nov;50(11):3580-90.

8.

[B cell targeting therapy using the anti-CD20 antibody in autoimmune diseases].

Tanaka Y.

Yakugaku Zasshi. 2009 Jun;129(6):675-9. Review. Japanese.

9.

[B lymphocyte].

Hasegawa M.

Nihon Rinsho Meneki Gakkai Kaishi. 2005 Oct;28(5):300-8. Review. Japanese.

10.

B cell depletion therapy in systemic rheumatic diseases: different strokes for different folks?

Stohl W, Looney RJ.

Clin Immunol. 2006 Oct;121(1):1-12. Epub 2006 May 11. Review.

PMID:
16697258
11.

Monoclonal antibodies in the treatment of systemic lupus erythematosus.

Robak E, Robak T.

Curr Drug Targets. 2009 Jan;10(1):26-37. Review.

PMID:
19149533
12.

Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.

Dörner T.

J Rheumatol Suppl. 2006 May;77:3-11. Review.

PMID:
16652439
13.

[B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].

Kondo S, Akashi T, Katsuta H, Iwakiri R, Anzai K, Nagafuchi S, Niho Y, Harada M.

Fukuoka Igaku Zasshi. 2005 Apr;96(4):86-92. Review. Japanese.

PMID:
15991605
14.

B-cell depletion and repopulation in autoimmune diseases.

Pers JO, Daridon C, Bendaoud B, Devauchelle V, Berthou C, Saraux A, Youinou P.

Clin Rev Allergy Immunol. 2008 Feb;34(1):50-5. doi: 10.1007/s12016-007-8015-4. Review.

PMID:
18270858
15.

B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab.

Looney RJ, Anolik JH, Campbell D, Felgar RE, Young F, Arend LJ, Sloand JA, Rosenblatt J, Sanz I.

Arthritis Rheum. 2004 Aug;50(8):2580-9.

16.

B-cell depletion in autoimmune diseases. Advances in autoimmunity.

Guzman Moreno R.

Autoimmun Rev. 2009 Jun;8(7):585-90. doi: 10.1016/j.autrev.2009.02.003. Epub 2009 Feb 10.

PMID:
19393204
17.

Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus.

Albert D, Dunham J, Khan S, Stansberry J, Kolasinski S, Tsai D, Pullman-Mooar S, Barnack F, Striebich C, Looney RJ, Prak ET, Kimberly R, Zhang Y, Eisenberg R.

Ann Rheum Dis. 2008 Dec;67(12):1724-31. doi: 10.1136/ard.2007.083162. Epub 2008 Feb 4.

PMID:
18250115
18.

Depletion of B cells in murine lupus: efficacy and resistance.

Ahuja A, Shupe J, Dunn R, Kashgarian M, Kehry MR, Shlomchik MJ.

J Immunol. 2007 Sep 1;179(5):3351-61.

19.

The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus.

Anolik JH, Campbell D, Felgar RE, Young F, Sanz I, Rosenblatt J, Looney RJ.

Arthritis Rheum. 2003 Feb;48(2):455-9.

20.

Treatment of SLE with anti-CD20 monoclonal antibody.

Looney RJ, Anolik J, Sanz I.

Curr Dir Autoimmun. 2005;8:193-205. Review.

PMID:
15564722

Supplemental Content

Support Center